Walleye Capital Portfolio holdings
AUM
$10.8B
1-Year Return
8.39%
This Quarter Return
+2.1%
1 Year Return
+8.39%
3 Year Return
+34.69%
5 Year Return
+89.54%
10 Year Return
–
AUM
$68.3M
AUM Growth
–
Cap. Flow
+$68.3M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
29.39%
Holding
712
New
360
Increased
–
Reduced
–
Closed
–
Top Buys
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 11.49% |
| 2 | Consumer Discretionary | 9.63% |
| 3 | Technology | 9.63% |
| 4 | Industrials | 6.97% |
| 5 | Financials | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
276
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $27K | ﹤0.01% |
+200
| New | +$27K |
|
277
AstraZeneca
AZN
$253B
| $26K | ﹤0.01% |
+653
| New | +$26K |
|
278
Frontline
FRO
$4.93B
| $26K | ﹤0.01% |
+4,067
| New | +$26K |
|
279
Eli Lilly
LLY
$652B
| $26K | ﹤0.01% |
+200
| New | +$26K |
|
|
SPLK
280
DELISTED
Splunk Inc
SPLK
| $26K | ﹤0.01% |
+210
| New | +$26K |
|
281
Topgolf Callaway Brands
MODG
$1.7B
| $25K | ﹤0.01% |
+1,555
| New | +$25K |
|
282
Penske Automotive Group
PAG
$12.4B
| $25K | ﹤0.01% |
+552
| New | +$25K |
|
283
United Natural Foods
UNFI
$1.75B
| $25K | ﹤0.01% |
+1,900
| New | +$25K |
|
284
NCR Voyix
VYX
$1.84B
| $25K | ﹤0.01% |
+1,493
| New | +$25K |
|
285
Agios Pharmaceuticals
AGIO
$2.09B
| $24K | ﹤0.01% |
+354
| New | +$24K |
|
286
Cartesian Therapeutics
RNAC
$277M
| $24K | ﹤0.01% |
+333
| New | +$24K |
|
287
AbbVie
ABBV
$375B
| $23K | ﹤0.01% |
+280
| New | +$23K |
|
|
CRON
288
Cronos Group
CRON
$957M
| $22K | ﹤0.01% |
+1,183
| New | +$22K |
|
|
LOGM
289
DELISTED
LogMein, Inc.
LOGM
| $22K | ﹤0.01% |
+280
| New | +$22K |
|
290
Humana
HUM
$37B
| $21K | ﹤0.01% |
+80
| New | +$21K |
|
291
Johnson & Johnson
JNJ
$430B
| $21K | ﹤0.01% |
+150
| New | +$21K |
|
292
Precigen
PGEN
$1.3B
| $21K | ﹤0.01% |
+3,959
| New | +$21K |
|
293
Flex
FLEX
$20.8B
| $20K | ﹤0.01% |
+2,654
| New | +$20K |
|
294
Genesco
GCO
$360M
| $20K | ﹤0.01% |
+446
| New | +$20K |
|
295
Jones Lang LaSalle
JLL
$14.8B
| $20K | ﹤0.01% |
+130
| New | +$20K |
|
296
J.M. Smucker
SJM
$12B
| $20K | ﹤0.01% |
+170
| New | +$20K |
|
297
Dentsply Sirona
XRAY
$2.92B
| $20K | ﹤0.01% |
+400
| New | +$20K |
|
298
SM Energy
SM
$3.09B
| $19K | ﹤0.01% |
+1,062
| New | +$19K |
|
299
VF Corp
VFC
$5.86B
| $19K | ﹤0.01% |
+234
| New | +$19K |
|
|
ABMD
300
DELISTED
Abiomed Inc
ABMD
| $19K | ﹤0.01% |
+67
| New | +$19K |
|